MarketPeel
Insider Trading Intelligence
BC

Bregua Corp

JANX
10% OWNER · JANUX THERAPEUTICS, INC. · CIK 0001863287
FILING MIX · LIFETIME56%/44%
BUYS
5
SELLS
4
TOTAL VALUE
$1000.0K
COMPANIES
1
ACTIVE SINCE
Jun 2021
HOLDINGS NOW
3,690,427
AVG SELL PX
TRADE KIND
SHOWING 9 / 9
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
1 backtested trades · 8 horizonsHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Bregua Corp, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d1+100.00%+18.62%+0.01%+18.62%+18.62%
14d1+100.00%+36.55%+1.09%+35.46%+35.46%
30d1+100.00%+44.19%+2.76%+41.43%+41.43%
60d1+100.00%+64.21%+5.39%+58.81%+58.81%
90d1+100.00%+52.64%+5.55%+47.09%+47.09%
180d1+100.00%+6.57%+10.63%-4.07%-4.07%
1y1+0.00%-37.57%-9.49%-28.08%-28.08%
2y1+0.00%-29.49%+7.44%-36.93%-36.93%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
JANX · 3,690,427 shares · as of Jun 15, 2021
0937,3131,874,6252,811,9383,749,250SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2021
FLOW · 5 buys / 4 sellsCOVERAGE · 1 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
JANX
JANUX THERAPEUTICS, INC.
SALE
526,3160Jun 15, 2021Jun 16, 2021View →
JANX
JANUX THERAPEUTICS, INC.
PURCHASE
674,2113,443,304Jun 15, 2021Jun 16, 2021View →
JANX
JANUX THERAPEUTICS, INC.
SALE
888,8880Jun 15, 2021Jun 16, 2021View →
JANX
JANUX THERAPEUTICS, INC.
PURCHASE
1,138,6651,138,665Jun 15, 2021Jun 16, 2021View →
JANX
JANUX THERAPEUTICS, INC.
PURCHASE
1,630,4282,769,093Jun 15, 2021Jun 16, 2021View →
JANX
JANUX THERAPEUTICS, INC.
SALE
1,272,7780Jun 15, 2021Jun 16, 2021View →
JANX
JANUX THERAPEUTICS, INC.
PURCHASE
58,823$17.00$1000.0K3,749,250Jun 15, 2021Jun 16, 2021View →
JANX
JANUX THERAPEUTICS, INC.
SALE
192,9140Jun 15, 2021Jun 16, 2021View →
JANX
JANUX THERAPEUTICS, INC.
PURCHASE
247,1233,690,427Jun 15, 2021Jun 16, 2021View →
Other insiders · JANX
Loading peer insiders…
About this filer
CIK 0001863287
ROLE
10% Owner
PRIMARY
JANX
COMPANIES
1
ACTIVE SINCE
Jun 2021
MARKETPEEL · /INSIDER/0001863287DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback